Glaxo appoints new chief executive
One of the world’s largest pharmaceutical firms GlaxoSmithKline today announced a replacement for chief executive Jean-Paul Garnier.
Andrew Witty, 43, currently president for Glaxo’s European pharmaceuticals arm, will succeed Mr Garnier when he retires at the end of May.